DekaBank Deutsche Girozentrale’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding EWTX
PCM
SAM
QPW
DekaBank Deutsche Girozentrale's EWTX Position: Q2 2026 in Review
DekaBank Deutsche Girozentrale held its Edgewise Therapeutics (EWTX) position steady in Q2 2026 at 80,000 shares worth $2.52M. The position accounts for ﹤0.01% of the portfolio, ranked #666.
DekaBank Deutsche Girozentrale first reported a position in EWTX in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.57M in Q1 2026. 73 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.
- DekaBank Deutsche Girozentrale held 80,000 shares of Edgewise Therapeutics worth $2.52M as of Q2 2026.
- DekaBank Deutsche Girozentrale left its Edgewise Therapeutics share count unchanged in Q2 2026.
- Edgewise Therapeutics made up ﹤0.01% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #666 holding.
- DekaBank Deutsche Girozentrale first reported a position in Edgewise Therapeutics in Q4 2021 and has held it in 19 quarters since.
- DekaBank Deutsche Girozentrale's Edgewise Therapeutics position peaked at $2.57M in Q1 2026.
- 73 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.